Molecular docking based screening of Listeriolysin-O for improved inhibitors.
Ghafari S, Komeilian M, Hashemi MS, Oushani S, Rigi G, Rashidieh B, Yarahmadi K, Khoddam F.
Ghafari S, et al.
Bioinformation. 2017 May 31;13(5):160-163. doi: 10.6026/97320630013160. eCollection 2017.
Bioinformation. 2017.
PMID: 28690383
Free PMC article.
This resulted in five hits that were further analyzed for pharmacological properties. The hit #1 (2-methyloctadecane- 1, 3, 4-triol) was further refined using appropriate modifications for creating a suitable pharmacophore model LLO inhibition. ...
This resulted in five hits that were further analyzed for pharmacological properties. The hit #1 (2-methyloctadecane- 1, 3, 4- …